Literature DB >> 7654691

Hydrophobic amino acid residues of human anticoagulation protein C that contribute to its functional binding to phospholipid Vesicles.

W T Christiansen1, L R Jalbert, R M Robertson, A Jhingan, M Prorok, F J Castellino.   

Abstract

The contributions to functional phospholipid (PL) binding of the cluster of amino acid side chains of human protein C (PC) comprising F4, L5, and L8 have been assessed by construction of mutants of PC and activated protein C (APC) designed wherein a hydrophilic side chain replaced the wild-type hydrophobic groups at these positions. The PL-dependent plasma-based anticoagulant activities of [F4Q]-r-APC and [L8Q]r-APC were severely reduced to 5% and < 2%, respectively, of wild-type r-APC. Activity losses of the mutants toward inactivation of coagulation factor VIII, measured in the complete in vitro tenase system, have also been observed. As evidenced through Ca(2+)-induced intrinsic fluorescence changes, both [F4Q]r-PC and [L8Q]r-PC were able to adopt Ca(2+)-dependent conformations that appeared similar to that of wtr-PC, ruling out shortcomings associated with such Ca(2+)-induced transitions as the basis for their anticoagulant activity losses. However, despite this, [L8Q]r-PC showed greatly defective macroscopic binding properties to PL vesicles, as did to a lesser extent [F4Q]r-PC. These findings were similar to those reported previously for [L5Q]r-PC/APC [Zhang, L., & Castellino, F. J. (1994) J. Biol. Chem. 269, 3590-3595]. We thus propose that the PL-dependent activity losses of these mutants are related to their suboptimal binding to PL or to their misorientation on the PL surface leading to poor alignment of the active sites of the r-APC mutants with the complementary cleavage sites on fVIII/fVIIIa and fV/fVa.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7654691     DOI: 10.1021/bi00033a008

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Modeling zymogen protein C.

Authors:  L Perera; C Foley; T A Darden; D Stafford; T Mather; C T Esmon; L G Pedersen
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

2.  C-terminal residues of activated protein C light chain contribute to its anticoagulant and cytoprotective activities.

Authors:  Atsuki Yamashita; Yuqi Zhang; Michel F Sanner; John H Griffin; Laurent O Mosnier
Journal:  J Thromb Haemost       Date:  2020-03-05       Impact factor: 5.824

3.  Adsorption of bovine prothrombin to spread phospholipid monolayers.

Authors:  E H Ellison; F J Castellino
Journal:  Biophys J       Date:  1997-06       Impact factor: 4.033

4.  Highly conserved residue arginine-15 is required for the Ca2+-dependent properties of the gamma-carboxyglutamic acid domain of human anticoagulation protein C and activated protein C.

Authors:  A Thariath; F J Castellino
Journal:  Biochem J       Date:  1997-02-15       Impact factor: 3.857

5.  An ordered sequential mechanism for Factor IX and Factor IXa binding to platelet receptors in the assembly of the Factor X-activating complex.

Authors:  Xia Yang; Peter N Walsh
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

6.  Structural changes in factor VIIa induced by Ca2+ and tissue factor studied using circular dichroism spectroscopy.

Authors:  P O Freskgård; O H Olsen; E Persson
Journal:  Protein Sci       Date:  1996-08       Impact factor: 6.725

7.  Effects of water soluble phosphotidylserine on bovine factor Xa: functional and structural changes plus dimerization.

Authors:  Rinku Majumder; Jianfang Wang; Barry R Lentz
Journal:  Biophys J       Date:  2003-02       Impact factor: 4.033

8.  Computational study of coagulation factor VIIa's affinity for phospholipid membranes.

Authors:  Olivier Taboureau; Ole Hvilsted Olsen
Journal:  Eur Biophys J       Date:  2006-11-28       Impact factor: 2.095

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.